化学物質の内分泌かく乱作用に関する環境省の今後の対応方針について
|
|
|
- ゆみか ひろもり
- 5 years ago
- Views:
Transcription
1 ExTEND
2 ExTEND2005 Enhanced Tack on Endocrine Disruption
3 10 (1998 )5 - SPEED'98-12 (2000 ) ( SPEED'98 ) 14 (2002 )8 (WHO)/ (ILO)/ (UNEP) Global Assessment of the State-of-the-Science of Endocrine Disruptors( WHO ) (OECD) 15 (2003 )5 15 (2003 ) 2 SPEED'98 ( )
4 1 3 SPEED 98 3 SPEED 98 4 (1) 4 (2) 5 (3) 8 (4) (1) 16 (2) 18 (3) 20 (4) 24 (5) 27 (6) 27 (7) WHO SPEED
5 SPEED (1998 ) ( )
6 SPEED (1998 ) SPEED 98 (1) ( ) ( ) POPs 1 ( ) 2 : : : ( ) - 4 -
7 SPEED 98 (in vitro ) ( ) ( )4-t- 23 (o,p -DDT p,p -DDE ) OECD ( )
8 (1421 ) (HSI) ( 70 ) (G SI) (H S I) (F 0 : 100 ) (F 1 : 70 ) (G SI) (HSI) (F 0 ) 2 (F 1 ) (180 )
9 t- ( ) cis- 2,4-4- trans- 4- ( ) ( ) A ( ) ( ) -2- -n- - ( ) p,p - p,p - ( ) o,p - ( ) p,p -
10 SPEED ( ) (Hershberger )
11 ( ) ( ) ( ) ( ) ( ) 4-t- ( ) cis- ( ) 2,4- ( ) 4- ( ) trans- ( ) 4- ( ) ( ) A ( ) ( ) -2- ( ) ( ) -n- ( ) ( ) ( ) ( ) ( ) - ( ) ( ) ( ) ( ) p,p - ( ) p,p - E ( ) o,p - ( ) p,p - ( )
12 (4-14-2) 4-1 (1) A ( ) PCB DDT (HCB) (HCH) PCB ( ) 80% Total PCB / PCB ( )
13 4-2 (2) 10 3 (20 60 ) (2000).,70:
14 (4) 10 (1998 ) OECD WHO ( ) H10 H11 H12 H13 H14 H15 H ( ( 16 ) (OECD) OECD ( enhanced TG211 enhanced TG206) OECD ( (WHO)WHO/ILO/UNEP 14 WHO WHO (
15 () - 13-
16 OECD - 14-
17 (1) (2) (3) (4) (5) (6) (7) WHO 11 WHO 12 IUPAC EC WHO (2002) Global assessment of the state-of-the-science of endocrine disruptors, WHO/IPCS/EDC/ WHO/UNEP/ILO (2004) Report of the joint IPCS-Japan workshop on Endocrine disruptors: Research needs and future directions, WHO/IPCS/EDC/01/ J. Miyamoto and J. Burger (2003) Implication of Endocrine Active Substances for Human and Wildlife, Scope/IUPAC. 14 EC (2001) Communication from the Commission to the Council and the European Parliament on the implementation of the Community Strategy for Endocrine Disrupters- A range of substances suspected of interfering with the hormone systems of humans and wildlife (COM(1999)706), COM(2001)262final
18 (1) ( ) (4 ) - 16-
19 ( )
20 (2) 10 (1998 ) SPEED 98 ( ) 49 (1973 ) ( ) ) ) ) ) ) - 18-
21 ( ) ( )
22 (3) 10 (1998 ) () OECD
23 ( ) (in vivo ) 15 ) ) (in vitro ) ( ) USEPA(1998)Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC) Final Report - 21-
24 ) DNA DNA () ) ) / / ) ) in vivo - 22-
25 ) ) ) in vitro in vivo in vitro in vivo ) OECD - 23-
26 (4) (6) ( ) - 24-
27 - 25-
28 OECD OECD 20 OECD in vivo - 26-
29 (5) ( ) ( ) (6) - 27-
30 (7) 10 (1998 ) ( ) ) - 28-
31 ) 1) 2) - 29-
32 ) ( )
33
34 - 32-
35 LC/MS
36
/ 3 1 / 3 / 3 1 /
8-18-29 3 291415 297 1-11-4 3/31/ 3/31/ 29 8 22 29 1 17 24 8-1 29 [1] PCB [2] HCB [3] [4] [5] DDT [6-1] p,p'-ddt [6-2] p,p'-dde pg/l ( ) nd 2,4 (46/47) 2.9 18 (47/47) 84 12 pg/g-dry ( ) nd 61, (61/62)
( ( ( (
2005 11 1...- 1-2...- 6-2.1...- 6-2.2...- 6-3...- 7-4...- 9-4.1...- 9-4.2...- 15 - (1...- 16 - (2...- 17 - (3...- 18 - (4...- 19-5...- 20 - 1 A ( BPA 1961 2003 40 (p.5 9 ( PC ( EX BPA PC CD DVD OA EX BPA
untitled
1.EU 1975 (75/442/EEC) Council Directive of 15 July 1975 on Waste 91/156/EEC91/692/EEC96/350/EC 1994 94/62/EC European Parliament and Council Directive 94/62/EC of 20 December 1994 on packaging and packaging
CAS NC(CH 2 ) 4 CN 1,4- C 6 H 8 N c.c d = Pa
1 200117 21512 CAS 111693 110 NC(CH 2 ) 4 CN 1,4- C 6 H 8 N 2 108.14 1 99 2-1. 2 1 295 159 c.c. 550 3 1.7-4.9 20 d 0.965 4 3.73 = 1 0.3 Pa 0.002 mmhg20 2 log Pow-0.32 m/z 41, 1.0 68 0.54 54 0.43 4 Koc9-16
124
[ ] [ ] 18 123 124 ( ) 125 126 127 128 5,683,062 2,306,419 18.2 14.0 12 5389 87 13 257 88 12 22 27 56.7 41.6 1 1.7 15 129 55 38.8 13.3 15 2004 15 1 3 84.8 29.3 1 23.9 38.0 10 10 35 35 15 5 56.5.31 55.4.1
untitled
1 JAPAN TESTING ASSOCIATION 2 3 JAPAN TESTING ASSOCIATION 4 5 JAPAN TESTING ASSOCIATION 6 7 JAPAN TESTING ASSOCIATION 8 9 JAPAN TESTING ASSOCIATION 10 11 JAPAN TESTING ASSOCIATION 12 13 JAPAN TESTING ASSOCIATION
t 492 t mg/l 30 mg/l BOD 95 OH = cm 3 / sec 25 8 OH /cm 3 12 = ph ph
2-1 200169 2740 CAS 110-49-6 1103 2- O H 3 C C O CH 2 CH 2 O CH 3 C 5 H 10 O 3 118.13 200168 2-1 99 2-1. 2 2, 3-65 2, 3 144145 45 o.c. 3 392 3 1.512.3 d19 1.009 2 4.07 = 1 30 Pa 0.23 mmhg20 2 4 log Pow0.10
Microsoft Word - 沖縄を取り巻く国際環境と地域協力の意義0520.docx
26 26 1 1 7 2 EU 25 39 21 Toffler, Alvin 3 Nye, Joseph S. 21 competitiveness EU 2000 1 1 3 20 3 FTA 200 2010 GDP 5 8,000 5 4,000 2014 6 2013 GDP 2012 5 9,000 1 4 9,000 2012 1 5,000 9 2010 GDP 2013 GDP
3_1_2モニタリングHP掲載用
総 PCB HCB 調査対象物質 [] アルドリン 表 1(1/) 平成 29 年度 POPs モニタリング調査結果 水質 (pg/l) 底質 (pg/g-dry) 範囲範囲 ~2,00 ~610,000 8 (6/),600 2.9~180 ~11,000 82 [] ディルドリン エンドリン DDT 類 [6-1] p,p'-ddt [6-2] p,p'-dde [6-] p,p'-ddd [6-]
H25震災追跡調査結果(概要)
平成 25 年度調査結果概要 ( 媒体 : 気単位 : pg/m 3 ) 1 2 3 4 PCB 類 3-2 p,p -DDT p,p -DDE 3-3 p,p -DDD 3-4 3-4-1 cis- クロルデン 4-2 trans- クロルデン 4-3 オキシクロルデン 4-4 o,p -DDT 3-5 o,p -DDE o,p -DDD HCB( ヘキサクロロベンゼン ) 3-1 cis- ノナクロル
,309 t 22,069 t 7,240 t µg/l µg/l < ,431-70, , , mg/l m
1 20019 1527 CAS 1317368 1230 PbO 223.20 1 99 1. 2 888 2 9.53 0.017 g/l 20 3 3 2 2. 10 29,309 t 22,069 t 7,240 t 4 1 3. 1 2 3.5 6 1 µg/l 9.1-24 2 µg/l < 43 6 27,431-70,000 4.5-1,300 13.4-17 31.7 0.48-3,459
外因性内分泌攪乱化学物質調査暫定マニュアル（水質、底質、水生生物）
p,p -DDT p,p -DDE p,p -DDD trans- cis- trans- cis- (PBB) (BaP) 25ng/L 5µg/kg GC/MS-SIM GC/MS-SIM GC/MS-SIM GC/MS-SIM (2-, 3-, 4- ) (4,4'- ) p,p'-ddt- 13 C 12 HCB- 13 C 6 BaP-d 12 -d10 -d 10 p- -d 14 1000
‚å„´561-2™ƒfi⁄
EU Social Inclusion Social Exclusion EU EU a EUCommunication from the Commission to the Council, the European Parliament, the European Economic and Social Committee and the Committee of the Regions-joint
1 CSR EU 2 CSR IT 5 CSR CRS OECD SA ISO CSR CSR 30 CSR 30 CSR 30 CSR 30 0
1. Corporate Social Responsibility CSR 2. CSR CSR EU CSR 3. CSR IT 4. CSR Socially Responsible Investment SRI CSR CSR 5. SRI CSR SRI 12% CSR NGO SRI SRI CSR CSR 6. OCED SA8000 ISO CSR 7. CSR CSR CSR 1
1
1 1. 2 1-1. 2 3 1-2.2 4 2. 5 6 7 2-1 2-2 2-3 2-4 2-5 2-1 2-2 2-3 2-4 2-5 PDF PDF 8 P10 9 2-1. 10 2-1. 11 2-1. ( ( 12 2-1. 24 13 2-1. 3 3 14 2-1. 15 2-2. 16 17 2-2. 3 18 2-2. 19 2712 3 1000 20 2841 21 ...
日経テレコン料金表（2016年4月）
1 2 3 4 8,000 15,000 22,000 29,000 5 6 7 8 36,000 42,000 48,000 54,000 9 10 20 30 60,000 66,000 126,000 166,000 50 100 246,000 396,000 1 25 8,000 7,000 620 2150 6,000 4,000 51100 101200 3,000 1,000 201
73 p.1 22 16 2004p.152
1987 p.80 72 73 p.1 22 16 2004p.152 281895 1930 1931 12 28 1930 10 27 12 134 74 75 10 27 47.6 1910 1925 10 10 76 10 11 12 139 p.287 p.10 11 pp.3-4 1917 p.284 77 78 10 13 10 p.6 1936 79 15 15 30 80 pp.499-501
122011pp.139174 18501933
122011pp.139174 18501933 122011 1850 3 187912 3 1850 8 1933 84 4 1871 12 1879 5 2 1 9 15 1 1 5 3 3 3 6 19 9 9 6 28 7 7 4 1140 9 4 3 5750 58 4 3 1 57 2 122011 3 4 134,500,000 4,020,000 11,600,000 5 2 678.00m
2 2 3 4 5 5 2 7 3 4 6 1 3 4 7 4 2 2 2 4 2 3 3 4 5 1932 A p. 40. 1893 A p. 224, p. 226. 1893 B pp. 1 2. p. 3.
1 73 72 1 1844 11 9 1844 12 18 5 1916 1 11 72 1 73 2 1862 3 1870 2 1862 6 1873 1 3 4 3 4 7 2 3 4 5 3 5 4 2007 p. 117. 2 2 3 4 5 5 2 7 3 4 6 1 3 4 7 4 2 2 2 4 2 3 3 4 5 1932 A p. 40. 1893 A p. 224, p. 226.
Microsoft Word - 映画『東京裁判』を観て.doc
1 2 3 4 5 6 7 1 2008. 2 2010, 3 2010. p.1 4 2008 p.202 5 2008. p.228 6 2011. 7 / 2008. pp.3-4 1 8 1 9 10 11 8 2008, p.7 9 2011. p.41 10.51 11 2009. p. 2 12 13 14 12 2008. p.4 13 2008, p.7-8 14 2008. p.126
() L () 20 1
() 25 1 10 1 0 0 0 1 2 3 4 5 6 2 3 4 9308510 4432193 L () 20 1 PP 200,000 P13P14 3 0123456 12345 1234561 2 4 5 6 25 1 10 7 1 8 10 / L 10 9 10 11 () ( ) TEL 23 12 7 38 13 14 15 16 17 18 L 19 20 1000123456
308 ( ) p.121
307 1944 1 1920 1995 2 3 4 5 308 ( ) p.121 309 10 12 310 6 7 ( ) ( ) ( ) 50 311 p.120 p.142 ( ) ( ) p.117 p.124 p.118 312 8 p.125 313 p.121 p.122 p.126 p.128 p.156 p.119 p.122 314 p.153 9 315 p.142 p.153
戦後の補欠選挙
1 2 11 3 4, 1968, p.429., pp.140-141. 76 2005.12 20 14 5 2110 25 6 22 7 25 8 4919 9 22 10 11 12 13 58154 14 15 1447 79 2042 21 79 2243 25100 113 2211 71 113 113 29 p.85 2005.12 77 16 29 12 10 10 17 18
29 2011 3 4 1 19 5 2 21 6 21 2 21 7 2 23 21 8 21 1 20 21 1 22 20 p.61 21 1 21 21 1 23
29 2011 3 pp.55 86 19 1886 2 13 1 1 21 1888 1 13 2 3,500 3 5 5 50 4 1959 6 p.241 21 1 13 2 p.14 1988 p.2 21 1 15 29 2011 3 4 1 19 5 2 21 6 21 2 21 7 2 23 21 8 21 1 20 21 1 22 20 p.61 21 1 21 21 1 23 1
http://www.who.int/ipcs/publications/ehc/en/index.html EHC 1 2 3 4 / EHC http://www.nihs.go.jp/dcbi/publist/ehchsg/ 1-8) WHO/IPCS CICAD (Concise Inter
3 [ ] Priority IARC JMPR 2004 10 Priority 1 Priority 1 Priority 2 Priority 3 Priority 1 1-1) CERI) http://www.cerij.or.jp/ceri_jp/koukai/sheet/sheet_indx4.htm http://www.safe.nite.go.jp/data/sougou/pk_list.html?table_name=hyoka&rank=sh
Press Release European Charter for Small Enterprises Enterprise Europe SME Action Programme The Enterprise Dimension Essential to Community Growth Integrated Programme in favour of SMEs
a 1 No
Fuchigami Shigenobu ILO19000 1 401 2 2011 12 1 250,000 200,000 150,000 100,000 450,000 400,000 350,000 300,000 250,000 200,000 150,000 50,000 100,000 50,000 0 1975 80 85 90 95 2000 05 0 10 No. 61220126
AFC_771本文.indd
11 2014 11 2014 3 7 11 15 23 27 2 19 22 25 31 30 34 35 36 36 36 36 37 38 2 Toshikazu Yoshikawa 3 4 5 6 Takashi Higashiguchi 7 8 9 10 11 12 13 14 Report on research 15 Report on research 16 17 Report on
3, ,104 t mg/l 30 mg/l BOD mg 14 C 8, /kg 11 8, 1 11 OH = cm 3 / sec 11 OH /cm ppm
3, 3-1 200019 4800 CAS 91941 1138 3, 3-4, 4 - -3, 3 - H 2 N Cl Cl NH 2 C 12 H 10 C l2 N 2 253.13 1 95 1. 2 3, 4 132-133 402 5 >200 5 700kg/m 3 5 8.73 = 1 5.610-8 kpa 4.210-7 mmhg20 4 6 log Pow3.51 3.57
untitled
.997, 2007.3.22 FP7 7 (FP7)EU NEDO 1 EU 7 (FP7) 1 NEDO FP7 1) FP7 1. 7 FP7 (1) (2)FP7 (3)FP7 2. FP7 (1)FP7 (2)FP7 (3)FP7 3. FP7 (1) (2)(ERC) (1) NEDO FP7 (2) EU () (3) 7 FP7 1. 7 FP7 (1) EU 1984 1 5 2006
橡アジポニトリル.PDF
1 200117 21512( ) CAS 111693 110( ) 1,4- NC(CH 2 ) 4 CN C 6 H 8 N 2 108.14 1) 99 2-1. 2) 1 2) 295 2) 159(c.c.) 3) 550 3) 1.7-4.9 vol % ( ) 3) d 20 0.965 2) 3.73 ( = 1) 4 0.3 Pa (0.002 mmhg) (20) 2) log
CAS H 3 C C CH 2 C 9 H tert d = hpa
1 200140 35 CAS 98839 1335-2- H 3 C C CH 2 C 9 H 10 118.18 1 99 4-tert- 1. 2-23.2 2 163164 2 54 574 3 0.96.6 20 d 4 0.9082 2 4.07 = 1 2.5 hpa 1.9 mmhg20 2 4 log Pow3.48 3.44 m/z 118, 1.0 103 0.58 91 0.21
橡96-07.PDF
1 967 2482 CAS 50000 CH 2 O 30.03 2952% 12.5 % 1. 2) -92 2) -19.5 2) 5085 3) 424 3) 7.073.0% 4) 20 d 4 0.815 5) 1.03 ( = 1) 5) 1.33 kpa (10 mmhg) (-88.0) 2) log Pow0.35 ( ) 6) 0.35 ( ) 7) 1) m/z 29 ( 1.0
60 18 3 12 30 1 25 6 14 2 25 5 28 3 1 6 7 3 12 HP - -2013-30 http://www.meti.go.jp/press/2013/11/20131126001/20131126001.html
59 ICT * IT 1990 20 100 20 2,000 OJT 2014 ICT * 60 18 3 12 30 1 25 6 14 2 25 5 28 3 1 6 7 3 12 HP - -2013-30 http://www.meti.go.jp/press/2013/11/20131126001/20131126001.html 61 2014 11 4 2014 1,467 2 3
立命館
SPORT AND HEALTH SCIENCE Research Study Report 2011 01 02 03 Sport and Health Science 04 PICK UP VOICE 05 Sport and Health Science 06 PICK UP VOICE 07 Sport and Health Science PICK UP VOICE 08 09 Sport
1) Towards European citizenship. Bulletin of the EC Supplement 7/1975. 2) Ibid., pp. 12-16. 3) A People's Europe. Bulletin of the EC Supplement 7/1985. A general system for the recognition of higher education
EU EU ECHR EU ECHR EU EC/EU EEC EC European Court of Justice, ECJ EU EC EC Solange I ECJ Solange II ECJ EC
EU ECHR EU Charter of Fundamental Rights of the European Union EU EC Treaty of Lisbon Amending the Treaty on European Union and the Treaty Establishing the European Community EU ECHR, European Convention
初等教育普及の観点から見たパラフォーマル教育システムの考察
Batley, R.A., Hussain, M., Khan, A. R., Mumtaz, Z., Palmer, N., & Sansom, K. R. (2004). Pakistan: Nonstate Providers of Basic Services. IDD. University of Birmingham. http://www.idd.bham.ac.uk/service-providers/
グリーンエネルギー普及拡大における太陽光発電の寄与
2 2 2 2 2 PV 3 ( 8.3) ( 26.7) NEDO 2001 4 5 40MW160MW 6 7 PV Si * 8 9 200 150 100 50 0 250 20 539 32 40 1,065 111 1,986 5,654 147 6,352 160 15,879 178 25,151 20,877 235 232 38,262 46,760 1994 1995 1996
皮膚刺激性試験のための 3 種の in vitro アッセイの UN GHS 下における性能および ECVAM による皮膚刺激性の性能標準における参照物質と正確性の値の適用に関する声明 2009 年 3 月 9-10 日に開催された欧州代替法評価センター科学諮問委員会 (ESAC) の第 30 回会
皮膚刺激性試験のための 3 種の in vitro アッセイの UN GHS 下における性能および ECVAM による皮膚刺激性の性能標準における参照物質と正確性の値の適用に関する声明 2009 年 3 月 9-10 日に開催された欧州代替法評価センター科学諮問委員会 (ESAC) の第 30 回会議にて 非 常任メンバーは以下の声明を全会一致で了承した その後 明記された手続きにより ESAC 事務局での校了と
住宅（本文、図表）
360 1970 90 1999 121 20 4.1 10 5-1 1990 1993 1.6 1.7 1996 1.55 1990 5-2 1970 98 5-3 41 141 80 1944 1.5 90 90 5-1 90 1991 5-4 150 1.99 5.44 99 2.08 2000 2.66 4.52 3.12 2.26 1.36 283 58 1.54 3.12 1.99 2.08
untitled
EU REACHEuPRoHS 1 2 2.1 REACH 2.1.1 REACH 2.1.2 2.2 EuP 2.3 RoHS 2.4 2.5 EU 2.6 1. (EU) REACH 1 (6 1 ) 2. 2.1 REACH 2.2 EuP 2 2005 4 2.3 RoHS 3 2.4 2007 2.5 2.6 1 (REACH:Registration,Evaluation,Authorization,and
untitled
NGO 2007 11 26 (JACSES) NGO FoE Japan (JACSES) 102-0072 2-3-2 401 TEL: 03-3556-7325 FAX: 03-3556-7328 162-0065 8-5 2 TEL03-3357-3800 FAX03-3357-3801 NGO FoE Japan 171-0014 3-30-8 1F TEL: 03-6907-7217 FAX:
1 1 1 32 594 2 38 1963-1 - 1962 J.F. 1964 1968 3 22 23 35 36 12 39 29 26 25 1 48 2 49 2 1 2 1 82-2 - 93 11 48 11 SG 1 11 SG SG 48 3 3 4 40 50 (1989)10 4 3-3 - 10 2 5 BSE 13 14 3 1980 11 4 2 1 2 2-4 - 2
取引法の観点からみた資金決済に関する諸問題
1 / /2010.1 105 1. 1 1 1 2008 5 2 2008 10 3 1 4 2007 8 1 2008 32 2 2008 5 12 2009 1 2009 2009 3 6 2008 12 2008 3 1842 32 4 2006 10 2009 4 2009 http://www.shojihomu.or.jp/saikenhou/indexja.html 2005 11
0 0 0 0............ PNEC.............................. PNECsed.................. 0 0 0 0 PNEC logpow. * Oncorhynchus mykisslc0. mg/l UFs0,000 0.000 mg/l0. µg/lpnec PNECwater PNECwater * Sangster, J. ()
リスクコミュニケーション概論
1 2005 7 2 http://hideyukihirakawa.com/ Contents 1. 2. 3. 4. 2 1. (Alvin Weinberg, 1972) e.g. etc 3 4 2. 5 NRC, 1989; Codex, 2004 ( ) ( ) NGO 6 2 (TRUSTNET: Dubreuil et al, 2002) www.trustnetgovernance.com
IT Information Technology Information and Communication Technology E mail IT -84-
Protection of personal information and privacy Shinako MATSUI* * 17 19 * -83- IT Information Technology Information and Communication Technology E mail 18 15 17 IT -84- -85- 1980 OECD Guidelines on the
030514第１回資料２－４最終
97.5% 2.5% 1.76% 0.76% 0.01% 14km 3 15 1 12 % 0 20 40 60 80 100 62 81 85 0% - 25% 26% - 50% 51% - 75% 76% - 90% 91% - 100% 88 96 100 100 Global Water Supply and Sanitation Assessment 2000 Report 2 24 %
2EUの技術政策.PDF
1 2003/8, No.449 2 3 EU EU EU 4 ( ( ) ) EU (2003 ( ) 4 1 7,500 ) (1,043 (4 500 2002 ) 2002 ) COST 4 5 6 7 EC 163-173 7-11 (OJ C325, 24.12.2002) www.europa.eu.int/eur-lex/en/trearies/index.html (FP6) http://europa.eu.int/comm/research/fp6/documents/en.html
,977 t 157,977 t mg l mg l BOD 9398 % OH = cm 3 / sec 11 = cm 3 / sec OH = /
1 9625 2219 CAS 75569 1, 2-1, 2- H 2 C CH CH 3 C 3 H 6 O 58.08 1 99 % 1. 2 2, 3-112.13 2, 3 34.23-37 449 2.8-37 % 2 d 0 4 0.859 4 d 20 0.8304 2 2, 4 2.00 = 1 53.33 kpa 400 mmhg18 59.33 kpa 445 mmhg20 5
Microsoft Word _5_...j.^.....Opart1_...o.p_.....doc
5. 調査結果の概要 モニタリング調査の検出状況一覧を表 8-1 及び表 8-3 に 検出下限値一覧を表 8-2 及び表 8-4 に示した なお 調査結果の留意事項は以下のとおりである 全般検出下限値 (=MDL) 未満を 検出下限値以上定量下限値(=MQL) 未満の値を tr( ) として扱った 幾何平均値の算出においては は検出下限値の1/2として扱った 兵庫県では 5L 及び25Lの大量採水方式による調査を実施したが
表 紙 （０７年１１月号）／＊
2007 11 No.568 C O N T E N T S 1 11 NOVEMBER 2007 2 2 10 21 29 32 35 36 37 28 34 36 Nov 2007 1 IMO MSC DE DE MSC Goal Based New Ship Construction Standards : GBS 2 Nov 2007 GBS SLA GBS MSC IACS CSR GBS
- 108 -
3-107- - 108 - 3.1 3.1.1 3.1.2 3.1.2.1 5 LD50 LC50 ATE 3.1.1 1 2 3 4 5 (mg kg ) 5 50 300 2000 5000 a (mg kg ) 50 200 1000 2000 a (ppm) 100 500 2500 5000 a b mg 0.5 2.0 10 20 a b c d 0.05 0.5 1.0 5 (mg
Research 2 Vol.81, No.22013
2 5 8 12 4 16 14,15 15 17 17 18 19 20 21 22 22 23 24 26 7 11 14 25 29 30 31 27 27 28 32 16 29 31 1 Research 2 Vol.81, No.22013 Vol.81, No.22013 3 P r o d u c t s 4 Vol.81, No.22013 Research Vol.81, No.22013
自殺防止のために国が実施できる政策について
10 1998 8,2611,755 32 1899 82 18 646 701 1722 13 1880 1933 10 1998 13 2001 14 2002 12 2003. 17 10 suisidology 11 12 13 14 18 2003. 15 WHO WHO, WHO Statistical Information System (WHOSIS) 16 WHO, Suicide
CAS O C O * DOP* DEHP 2- C O O * n- C 24 H 38 O CH 2 CH 2 CH 2 CH 3 CH (CH 2 ) % 2- A BHT , 4
2-1 9628 31307 CAS 117817 2- O C O * DOP* DEHP 2- C O O * n- C 24 H 38 O 4 390.56 CH 2 CH 2 CH 2 CH 3 CH (CH 2 ) 3 1 99 % 2- ABHT 1. 2-55 3 3, 4 386 171 350 6 0.1 % d 20 4 0.9861 4 13.48 0.30410-4 Pa 2.2810-7
,161 t 9,753 t 2,408 t LC 50 mg/ L EC 50 mg/l * 5 : Selenastrum 6772-h, Sb 2 O 3, : capricornutum 6 3 Selenastrum h, Sb
1 20017 1543 CAS 1309644 125 Sb 2 O 3 291.52 1 99 1. 2 655 1,425 2 2 2 3 5.2 5.67 2 2 2. 10 12,161 t 9,753 t 2,408 t 4 3. 1 2 3 4. LC 50 mg/ L EC 50 mg/l * 5 : Selenastrum 6772-h, Sb 2 O 3, : capricornutum
No.7, (2006) A Survey of Legislation Regarding Environmental Information in Europe and Japan IWATA Motokazu Nihon University, Graduate School of
No.7, 35-44 (2006) A Survey of Legislation Regarding Environmental Information in Europe and Japan IWATA Motokazu Nihon University, Graduate School of Social and Cultural Studies As Principle 10 of the
untitled
2006 Progress Report on the Economic Well-Being of Working-Age People with Disabilities Employment of Disabled People in Europe in 2002 Statistics in Focus Code of Practice on Managing Disability in the
<95DB8C9288E397C389C88A E696E6462>
2011 Vol.60 No.2 p.138 147 Performance of the Japanese long-term care benefit: An International comparison based on OECD health data Mie MORIKAWA[1] Takako TSUTSUI[2] [1]National Institute of Public Health,
199510 156 8 19963 8 42 1620045 7 5 20872127 63 19082003 4 1929 7 1932 353946 34 58 68 106 59 4 1511 5 95 1995 40 42 2004.8.10 2005.4.30
2004 8 2005 5 pdf 2 199510 156/1 19951015611 3 4 5 JIS JIS X 0208, 1997 10o o http://www.pref.hiroshima.jp/soumu/bunsyo/monjokan/index.htm 199510 156 8 19963 8 42 1620045 7 5 20872127 63 19082003 4 1929
